Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND for Turning Point's TPX-0022

May 16, 2019

FDA approves Venclexta with Gazyva for previously untreated CLL or SLL

May 16, 2019

New phase I trial studies MK-8558 in antiretroviral-naive patients with HIV-1

May 16, 2019

FORMA Therapeutics discloses new HDAC6 inhibitors

May 16, 2019

Bayer describes new P2X purinoceptor 3 antagonists

May 16, 2019

New stroke therapy promotes motor recovery in mice

May 16, 2019

GABA-selective AAV therapy upregulates SCN1A to treat Dravet syndrome

May 16, 2019

Vertex and Kymera enter strategic research and development collaboration

May 16, 2019

Bispecific anti-VEGF/ANG-2 surrobody SL-634 shows potential to treat wet AMD

May 16, 2019

InFlectis BioScience announces phase I results for IFB-088

May 16, 2019

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...